Yes, thanks, Zach, lot of good questions in there. I would say, first off, yes, you have to remember that they report on book, we report on stage, so it's sometimes challenging to compare. But I would say, as I've said before, and I mentioned regarding cities, the mix has helped them. They've always been better in smaller markets, long-tail markets, etc. We've always been really strong in big cities. When cities were dragging, cities get built by international travelers and we also have been strong in long-haul air for those travelers, like all those mix effect actually impact things. And so, some -- some of them we want in, Vrbo has been a beneficiary, some of them we locked in big cities and international travels. So, it's always been a balance. We are less focused on room nights rather than room dollars, if you will. It's a little misleading. We could book a million more one-star hotels -- nights and it wouldn't mean much to our P&L, and we could book 100,000 5-star hotels, it wouldn't mean a lot. You have to take it all in balance, but we are feeling good about the recovery. And in general, our numbers, domestically, are running ahead, in lodging, of where we were 2 years ago. So, I think we're in good shape there and we feel good about that. And again, we have had a somewhat conservative bend along the game with COVID. We've been, Eric mentioned, tapping the brakes. We tried to respond. Sometimes we get over our skis, sometimes we're behind the recoveries. It's a balancing act, but we are getting more confident, more aggressive. And I think you'll see us continue to lean in to gain share across the globe. In terms of the COVID question, it remains to be seen at every, as Eric said, every story as its own. But I will tell you if you look at recent news, for example, of the COVID cases in the UK, spiking from recent openings and I was in London and it was amazingly open. I would say that queries have remained elevated since the international announcements to the U.S., and they remain elevated and we have not seen a pullback from the caseload news, so I think that remains strong. And of course, science is helping us out along the way. We just announced that kids will be able to be vaccinated in the U.S., which is a great benefit for society, let alone our business. And likewise, the announcement today about the UK approving the Merck pill for treatment. This is I think we all agree is probably going to be an endemic not a pandemic. And the more treatments we got, the more ways we got to deal with it, the better off we're all going to be.